Atlas Trials

The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection

Clinical trial NCT04252885 · COMPLETED

Trial details

NCT number
NCT04252885
Sponsor
Guangzhou 8th People's Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Coronavirus Infections
Start date
2020-01-28
Primary completion
2020-04-30
Enrollment
86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.